Articles in section Licensing
<< Joint Venture | 505 articles | Mergers & Acquisitions >> |
<< Previous | Pages 1 ..2 3 4 5 6 7 .. 51 | Next >> |
-
Genmab Licenses Synaffix’s Antibody-Drug Conjugate Technologies
-
AstraZeneca Pays US$200 M Upfront for Ionis’ Rare Disease Drug
-
Astellas Partners with Dyno Therapeutics for Gene Therapy Technology
-
Ironwood Begins to Rebolster its Pipeline with Cour’s Rare Disease Drug
-
Aridis Pharmaceuticals Licenses AstraZeneca’s late-stage monoclonal antibody, survatoxumab
-
Biogen Licenses InnoCare’s Orelabrutinib to Strengthen Multiple Sclerosis Presence
-
Novo Nordisk and Heartseed Enter into Agreement to Develop Cell therapy for Heart Failure
-
Akebia Expands Renal Disease Portfolio with Cyclerion’s Praliciguat
-
Genentech and Pieris Collaborate on Respiratory and Ophthalmology Therapies
-
BMS Bolsters Pipeline with Two Billion-Dollar Deals